We put the needs and experiences of patients at the core of our mission and purpose, working to turn cells into powerful therapeutics.
Naples, FL
Joined October 2017
- Tweets756
- Following150
- Followers819
- Likes58
Patient stories remind us what innovation is ultimately about. This month, we shared Mendya's voice. Countless others are still navigating diagnosis, treatment decisions, and recovery.
Keep asking questions, seeking answers, & advocating!
#PatientVoice #PatientAdvocacy
Progress is measured not only by advances in science, but by what those advances may make possible for patients.
At Gamida Cell, we invest in innovation and listen to patients to keep their priorities at the center.
Watch: youtu.be/UeCnF4sBEl8?si=GF_o…
#BloodCancerAwarenessMonth
On #WorldMarrowDonorDay, we recognize those who join donor registries, donate, and the families who donate cord blood.
Mendya's story is a reminder that behind every donor search is a person hoping for more time, more options, and a path forward.
Watch: youtu.be/UeCnF4sBEl8?si=TU9t…
For patients who need a stem cell transplant, uncertainty can be a stormy journey.
Will a match be found? Will a donor be available?
As World Marrow Donor Day approaches, we recognize all who help navigate that uncertainty.
#WorldMarrowDonorDay #BloodCancerAwarenessMonth
Today, #ApheresisAwarenessDay, we recognize those whose expertise helps make apheresis possible.
Join ASFA and Gamida Cell on Sept. 22 for an educational webinar featuring Dr. Zachary Crees: apheresis.org/event/Sep22202…
Some moments divide life into before and after.
For many people facing blood cancer, diagnosis is one of those moments. While every journey is unique, the shock and uncertainty of hearing life-changing news is something all patients share.
#BloodCancerAwarenessMonth #PatientVoice
For Mendya Griffith, an AML diagnosis brought fear, uncertainty, and questions about the future.
At Gamida Cell, the people behind the diagnosis are at the center of our work and remind us why continued innovation matters.
Watch Mendya's story:
youtu.be/UeCnF4sBEl8?si=v26r…
Before her AML diagnosis, Mendya worked in healthcare, stayed active, and had a clear vision for the future.
Behind every blood cancer diagnosis is a person with goals and dreams for what comes next.
Hear more of Mendya's story throughout September.
#BloodCancerAwarenessMonth
September is #BloodCancerAwarenessMonth.
This month, we’ll share the story of Mendya Griffith, an AML survivor and patient advocate, in her own words. We’re grateful to Mendya for helping others feel less alone. #PatientVoice #GamidaCell
Gamida Cell retweeted
Watch these recordings from the 2026 AAMDSIF Bone Marrow Failure Scientific Symposium:
Pathways of Clonal Progression arising from Germline Predisposition
Discussions include
From Polyclonal to Monoclonal
How to Optimize Diagnosis and Surveillance?
Watch the full session with 6 speakers: youtu.be/2C9oGSz6j8c
and
Clonality in Acquired Bone Marrow Failure, PNH, and VEXAS
Discussions include focus on PNH single-cell analysis, Clonality in its environment, and How therapies affect clonality
and
Clonality in Aplastic Anemia after IST - HLA, RAC E study data, NIH study data, and case discussion.
Watch the full session with 8 speakers: youtu.be/tR40fRaY0Nc
#bonemarrowfailureresearch #PNH #VEXAS
🎧 Podcast featuring Dr. Richard W. Childs, M.D., Rear Admiral, USPHS; Asst. Surgeon General; NHLBI, NIH discussing research for patients with severe aplastic anemia.
Proud to partner with @aamdsif to elevate education, advocacy, and awareness.
🎙️ Listen: youtu.be/CK_ISEiWo0w?si=VXG6…
At the center of every partnership in biotech is a shared goal: improving outcomes for patients facing serious diseases.
Our CBO Stephen Joyce joins @IAmBiotech in highlighting how collaboration across the biotech community helps move innovation forward.
For Stephen Joyce, Chief Business Officer of @GamidaCellTx, #BIO2026 marks a milestone - their 10th year of BIO Partnering™ meetings. See what keeps them coming back.
Learn more and register: convention.bio.org
There’s renewed energy in the SAA conversation. From patients to clinicians, new questions are shaping what comes next.
Proud to have our team on the ground in Seattle this weekend at @aamdsif listening and engaging as the dialogue evolves.
Progress starts with conversation.
Engaged on Capitol Hill on advancing #CellTherapy, #RareDisease, and #HSCT - and the policies that support patient access and innovation.
Appreciative of the leadership of @millermeeks & @RepJohnJoyce, including efforts to advance reauthorization of H.R. 5160
#PatientAdvocacy
Today, on World Blood Cancer Day, we recognize the strength and resilience of people affected by blood cancers worldwide.
Gamida Cell stands alongside patients and survivors like Mendya in supporting awareness and progress - today and every day.
#WorldBloodCancerDay
We are proud to support the launch of the American Biotech Innovation Alliance (ABIA), a coalition built to develop a roadmap to sustain & extend U.S. leadership in biotech.
biotechstrong.us/
Gamida Cell retweeted
RoslinCT has entered into a strategic partnership with Gamida Cell to manufacture their FDA-Approved Cell Therapy Omisirge®, a commercial product for the treatment of hematologic malignancies.
Read the full press release here: hubs.la/Q03bgG7H0
Exploring treatment options in allo-HSCT?
Join us on February 12, 1:30-2:30pm HST in PIT Room 3 as Dr. Stephanie Tsai and Dr. Ronit Simantov present “Options When a Matched Allo-HSCT is Not Available”. #Tandem25
WARNING: INFUSION REACTIONS, GRAFT VERSUS HOST DISEASE, ENGRAFTMENT SYNDROME, and GRAFT FAILURE. See Full Prescribing Information, including Boxed Warning, at lnkd.in/etxVyNF2 or visit Omisirge.com
Aloha! We're excited to be in Hawaii for #Tandem25! Stop by Gamida Cell Booth 101 to chat with our team and discover the benefits of Omisirge® (omidubicel-onlv).
WARNING: INFUSION REACTIONS, GRAFT VERSUS HOST DISEASE, ENGRAFTMENT SYNDROME, and GRAFT FAILURE. See full Prescribing Information, including Boxed Warning, at lnkd.in/etxVyNF2
Our team is arriving in San Diego! Visit our booths (2247 + 2346) at #ASH24 to learn more about Omisirge® (omidubicel-onlv).
WARNING: INFUSION REACTIONS, GRAFT VERSUS HOST DISEASE, ENGRAFTMENT SYNDROME, and GRAFT FAILURE. See full Prescribing Information, including Boxed Warning, at lnkd.in/etxVyNF2